country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-177497

Copy Link Print Information

SKLB-03220

SKLB-03220 is a selective and orally active EZH2 covalent inhibitor with an IC₅₀ of 1.72 nM for EZH2^MUT. SKLB-03220 exhibits weak activities against other tested histone methyltransferases (HMTs) and kinases. SKLB-03220 displays noteworthy potency against ovarian cancer cell lines and induces cell apoptosis. SKLB-03220 significantly inhibits tumor growth in PA-1 xenograft model. SKLB-03220 can be used for the study of ovarian cancer.

For research use only. We do not sell to patients.

CAS No.: 2852050-29-2
Formula: C₃₃H₄₀N₄O₄
Molecular Weight:556.70

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (276 KB)

SKLB-03220 Chemical Structure

CAS No.: 2852050-29-2

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

EZH2 WT

1.72 nM (IC₅₀)

EZH2 Y641N

EZH2 Y641F mutant type

All Histone Methyltransferase Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
4T1	IC₅₀	24.5 μM Compound: 12d; SKLB-03220	Antiproliferative activity against mouse 4T1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against mouse 4T1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
A2780	IC₅₀	11.2 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human A2780 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human A2780 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
A549	IC₅₀	28.7 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
BT-549	IC₅₀	18.9 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human BT-549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human BT-549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
ES-2	IC₅₀	36.4 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human ES2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human ES2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
HEY	IC₅₀	35.5 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human HEY cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human HEY cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
MCF7	IC₅₀	56.2 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
NCI-H1703	IC₅₀	26.3 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human NCI-H1703 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human NCI-H1703 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
OAW-42	IC₅₀	>100 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human OAW-42 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human OAW-42 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
OVCAR-3	IC₅₀	35.6 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human OVCAR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human OVCAR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
PA-1	IC₅₀	10.1 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human PA-1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human PA-1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
SK-BR-3	IC₅₀	22.8 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human SK-BR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human SK-BR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]
SK-OV-3	IC₅₀	56.4 μM Compound: 12d; SKLB-03220	Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 36692394]

In Vitro

SKLB-03220 (0.5-10 μM, 3-14 days) inhibits PA-1 and A2780 cell proliferation and colony formation^[1].
SKLB-03220 (5-40 μM, 48 h) induces apoptosis of PA-1 cells^[1].
SKLB-03220 (0-5 μM, 0-4 d) inhibits the expression of H3K27me3 in PA-1 cells^[1].
SKLB-03220 (10 μM, 3 d + washout 0-4 d) achieves persistent target inhibition and long-lasting anti-tumor effects in PA-1 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis^[1]

Cell Line:

PA-1 cells
Concentration:

5, 10, 20 and 40 μM
Incubation Time:

48 h
Result:

Induced ovarian cancer cell apoptosis in a dose-dependent manner.

Western Blot Analysis^[1]

Cell Line:

PA-1 cells
Concentration:

0, 0.3, 0.6, 1.2, 2.5 and 5 μM
Incubation Time:

0, 1, 2, 3, 4 d
Result:

Effectively and persistently reduced the level of H3K27me3 within the cells, without affecting the total protein quantity of EZH2.

Parmacokinetics

Species	Dose	Route	C_max	T_max	T_1/2	AUC_0-t	MRT_0-t	F	CL	V_ss
Rat^[1]	100 mg/kg	p.o.	6740.93 ng/mL	0.38 h	0.77 h	12615.91 μg/L·h	1.73 h	8.73 %	/	/
Rat^[1]	5 mg/kg	i.v.	22792.57 ng/mL	0.08 h	0.61 h	7725.47 μg/L·h	0.26 h	/	699.32 mL/min/kg	202.28 mL/kg

In Vivo

SKLB-03220 (75-150 mg/kg, p.o., twice daily for 21 days) significantly inhibits tumor growth and with good tolerance in PA-1 cells xenograft mice model^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

PA-1 cells xenograft model established in BALB/C nude mice (6 weeks)^[1]
Dosage:

75 and 150 mg/kg
Administration:

Oral administration (p.o.), twice daily for 21 days
Result:

Significantly inhibits tumor growth in a dose-dependent manner.
Reduced the Ki-67 and H3K27me3 signals and increased cleaved Caspase-3 in tumor tissues.
No significant abnormalities were observed in terms of body weight, blood routine, blood biochemical indicators, and pathological sections of major organs.

Chemical Information

CAS No. 2852050-29-2
Molecular Weight 556.70
Formula C₃₃H₄₀N₄O₄
SMILES

O=C(NC1=CC=C(C)C(C2=CC(N(C3CCOCC3)CC)=C(C)C(C(NCC4=C(C)C=C(C)NC4=O)=O)=C2)=C1)C=C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (276 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Zhang Q, et al. Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer. J Med Chem. 2023 Feb 9;66(3):1725-1741. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Amount: USD 0.00

Biological Activity
- Description
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

SKLB-03220

All Histone Methyltransferase Isoforms

Biological Activity

Chemical Information

Purity & Documentation

References

Calculators

Help & FAQs

SKLB-03220 Related Classifications

HY-177497 Related Classifications